There are three obstacles to faster development and deployment of non-addictive pain treatments. They are the business ...
The medication, trademarked JOURNAVX, offers opioid-like relief without the same risk of addiction. It has been accepted as a ...
A WOMAN was left with a “snowballing” addiction after being prescribed painkillers post-surgery, which she hid from her ...
Thirty EMS agencies across NC can administer buprenorphine in the field, bridging the gap between overdose and ongoing addiction treatment.
A New Orleans-based biotech company has developed a breakthrough non-opioid pain medication, which is backed by funding from Ochsner Ventures, the investment arm of Ochsner Health, and from Gulf South ...
The pain management field is currently driven by the urgent need to move beyond addictive opioids and treatment options than run the risk of toxicity at high doses, such as acetaminophen (APAP) and ...
Eli Lilly is expanding its pain drug pipeline with the acquisition of SiteOne Therapeutics, a startup with a lead program that addresses the same target as a Vertex Pharmaceuticals product whose ...
During my 30 years in the Indiana Senate, I witnessed numerous pieces of legislation aimed at toughening our drug policies and penalties. In my final years, I authored a series of bills that focused ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback